Dipsacoside B Attenuates Atherosclerosis by Promoting Autophagy to Inhibit Macrophage Lipid Accumulation
Open Access
- 27 September 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (10) , 1226
Abstract
Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and foam cell formation in the arterial wall. Promoting macrophage autophagy has emerged as a promising therapeutic strategy against atherosclerosis. Dipsacoside B (DB) is an oleanane-type pentacyclic triterpenoid saponin extracted from Lonicerae flos with potential anti-atherosclerotic properties. In this study, we investigated the effects of DB on atherosclerosis progression in ApoE−/− mice fed a high-fat diet and explored the underlying mechanisms in oxidized low-density lipoprotein (ox-LDL)-induced foam cells. DB treatment significantly reduced atherosclerotic lesion size, improved plaque stability, and regulated lipid metabolism without impairing liver and kidney function in ApoE−/− mice. In vitro studies revealed that DB dose-dependently inhibited ox-LDL internalization and intracellular lipid accumulation in RAW264.7 macrophages. Mechanistically, DB induced autophagy, as evidenced by increased autophagosome formation and upregulated expression of autophagy markers LC3-II and p62 both in vivo and in vitro. Inhibition of autophagy by chloroquine abolished the antiatherosclerotic and pro-autophagic effects of DB. Furthermore, DB treatment increased LC3-II and p62 mRNA levels, suggesting transcriptional regulation of autophagy. Collectively, our findings demonstrate that DB exerts anti-atherosclerotic effects by inhibiting foam cell formation via autophagy induction, providing new insights into the pharmacological actions of DB and its potential as a therapeutic agent against atherosclerosis.Keywords
Funding Information
- National Natural Science Foundation of China (82474115, 2022SK2011, 2021RC4064, 2023JJ40472, 22B0371, 22B0387)
- Key Research and Development Projects of Hunan Provincial Science and Technology Department (82474115, 2022SK2011, 2021RC4064, 2023JJ40472, 22B0371, 22B0387)
- science and technology innovation Program of Hunan Province (82474115, 2022SK2011, 2021RC4064, 2023JJ40472, 22B0371, 22B0387)
- Hunan Provincial Natural Science Foundation of China (82474115, 2022SK2011, 2021RC4064, 2023JJ40472, 22B0371, 22B0387)
- Department of Education of Hunan Province (82474115, 2022SK2011, 2021RC4064, 2023JJ40472, 22B0371, 22B0387)
This publication has 57 references indexed in Scilit:
- Saponins as therapeutic candidates for atherosclerosisPhytotherapy Research, 2024
- Macrophage profiling in atherosclerosis: understanding the unstable plaqueBasic Research in Cardiology, 2024
- Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemicalBiomedicine & Pharmacotherapy, 2023
- Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB–P300–BRD4 axisActa Pharmaceutica Sinica B, 2021
- Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarbBiomedicine & Pharmacotherapy, 2020
- Upregulation of the Autophagy Adaptor p62/SQSTM1 Prolongs Health and Lifespan in Middle-Aged DrosophilaCell Reports, 2019
- Soyasaponins Reduce Inflammation and Improve Serum Lipid Profiles and Glucose Homeostasis in High Fat Diet‐Induced Obese MiceMolecular Nutrition & Food Research, 2018
- Elatoside C protects against ox-LDL-induced HUVECs injury by FoxO1-mediated autophagy inductionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Macrophage Autophagy Plays a Protective Role in Advanced AtherosclerosisCell Metabolism, 2012
- Autophagy: Renovation of Cells and TissuesCell, 2011